Found: 99
Select item for more details and to access through your institution.
Mesothelin expression has prognostic value in stage ΙΙ/ΙΙΙ colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of serum mesothelin in malignant and benign ovarian masses.
- Published in:
- Archives of Gynecology & Obstetrics, 2014, v. 290, n. 1, p. 107, doi. 10.1007/s00404-014-3147-2
- By:
- Publication type:
- Article
Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.
- Published in:
- Archives of Gynecology & Obstetrics, 2014, v. 289, n. 6, p. 1309, doi. 10.1007/s00404-013-3128-x
- By:
- Publication type:
- Article
血清间皮素联合CDK6 诊断早期卵巢癌的临床价值研究.
- Published in:
- Progress in Modern Biomedicine, 2018, v. 18, n. 8, p. 1506, doi. 10.13241/j.cnki.pmb.2018.08.021
- By:
- Publication type:
- Article
Identification of Potential Prognostic Biomarkers Associated with Monocyte Infiltration in Lung Squamous Cell Carcinoma.
- Published in:
- BioMed Research International, 2022, p. 1, doi. 10.1155/2022/6860510
- By:
- Publication type:
- Article
C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.
- Published in:
- Journal of Gastroenterology, 2014, v. 49, n. 1, p. 81, doi. 10.1007/s00535-013-0773-6
- By:
- Publication type:
- Article
Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0646-9
- By:
- Publication type:
- Article
Significance of serum mesothelin in an asbestos-exposed population in the Czech Republic.
- Published in:
- Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2015, v. 159, n. 3, p. 472, doi. 10.5507/bp.2014.015
- By:
- Publication type:
- Article
Morphology of myeloproliferative neoplasms.
- Published in:
- International Journal of Laboratory Hematology, 2023, v. 45, p. 59, doi. 10.1111/ijlh.14086
- By:
- Publication type:
- Article
Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 3, p. 660, doi. 10.3390/ijms20030660
- By:
- Publication type:
- Article
A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Novel PET Imaging Using <sup> 64 </sup>Cu-Labeled Monoclonal Antibody against Mesothelin Commonly Expressed on Cancer Cells.
- Published in:
- Journal of Immunology Research, 2015, v. 2015, p. 1, doi. 10.1155/2015/268172
- By:
- Publication type:
- Article
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2013, v. 51, n. 9, p. 1815, doi. 10.1515/cclm-2013-0151
- By:
- Publication type:
- Article
A predictive equation to adjust for clinical variables in soluble mesothelin-related protein (SMRP) levels.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2012, v. 50, n. 12, p. 2199, doi. 10.1515/cclm-2012-0314
- By:
- Publication type:
- Article
Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2012, v. 50, n. 4, p. 721, doi. 10.1515/cclm.2011.816
- By:
- Publication type:
- Article
Non-islet cell tumor hypoglycemia caused by intrathoracic solitary fibrous tumor: a case report.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The value of mesothelin in the diagnosis and follow-up of surgically treated ovarian cancer.
- Published in:
- European Journal of Gynaecological Oncology, 2013, v. 34, n. 2, p. 163
- By:
- Publication type:
- Article
The Potential of CAR T Cell Therapy in Pancreatic Cancer.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02166
- By:
- Publication type:
- Article
Methylation-Associated Partial Down-Regulation of Mesothelin Causes Resistance to Anti-Mesothelin Immunotoxins in a Pancreatic Cancer Cell Line.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0122462
- By:
- Publication type:
- Article
Mesothelin Expression in Triple Negative Breast Carcinomas Correlates Significantly with Basal-Like Phenotype, Distant Metastases and Decreased Survival.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114900
- By:
- Publication type:
- Article
Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114483
- By:
- Publication type:
- Article
Rat N-ERC/Mesothelin as a Marker for In Vivo Screening of Drugs against Pancreas Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0111481
- By:
- Publication type:
- Article
Diagnostic Accuracy of Ber-EP4 for Metastatic Adenocarcinoma in Serous Effusions: A Meta-Analysis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0107741
- By:
- Publication type:
- Article
Megakaryocytic Potentiating Factor and Mature Mesothelin Stimulate the Growth of a Lung Cancer Cell Line in the Peritoneal Cavity of Mice.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104388
- By:
- Publication type:
- Article
Expansion of Anti-Mesothelin Specific CD4<sup>+</sup> and CD8<sup>+</sup> T Cell Responses in Patients with Pancreatic Carcinoma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088133
- By:
- Publication type:
- Article
CD90(+) Mesothelial-Like Cells in Peritoneal Fluid Promote Peritoneal Metastasis by Forming a Tumor Permissive Microenvironment.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086516
- By:
- Publication type:
- Article
<i>MSLN</i> Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0085935
- By:
- Publication type:
- Article
Novel Immunocytokine IL12-SS1 (Fv) Inhibits Mesothelioma Tumor Growth in Nude Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081919
- By:
- Publication type:
- Article
Combination Treatments with the PKC Inhibitor, Enzastaurin, Enhance the Cytotoxicity of the Anti-Mesothelin Immunotoxin, SS1P.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0075576
- By:
- Publication type:
- Article
Hyaluronan and N-ERC/Mesothelin as Key Biomarkers in a Specific Two-Step Model to Predict Pleural Malignant Mesothelioma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0072030
- By:
- Publication type:
- Article
Mesothelin Virus-Like Particle Immunization Controls Pancreatic Cancer Growth through CD8<sup>+</sup> T Cell Induction and Reduction in the Frequency of CD4<sup>+</sup>foxp3<sup>+</sup>ICOS<sup>−</sup> Regulatory T Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0068303
- By:
- Publication type:
- Article
A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0040157
- By:
- Publication type:
- Article
Inhibition of Mesothelin as a Novel Strategy for Targeting Cancer Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0033214
- By:
- Publication type:
- Article
Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells.
- Published in:
- Molecular Cancer, 2017, v. 16, p. 1, doi. 10.1186/s12943-017-0633-8
- By:
- Publication type:
- Article
Tumor immunotherapy with mesothelin-targeted drugs: opportunities and challenges.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 9, p. 841, doi. 10.3872/j.issn.1007-385X.2024.09.001
- By:
- Publication type:
- Article
Association between mesothelin expression and survival outcomes in patients with triple-negative breast cancer: a protocol for a systematic review.
- Published in:
- Systematic Reviews, 2016, v. 5, p. 1, doi. 10.1186/s13643-016-0313-6
- By:
- Publication type:
- Article
Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.
- Published in:
- Lung, 2016, v. 194, n. 3, p. 409, doi. 10.1007/s00408-016-9868-1
- By:
- Publication type:
- Article
Serum Biomarkers in Patients with Mesothelioma and Pleural Plaques and Healthy Subjects Exposed to Naturally Occurring Asbestos.
- Published in:
- Lung, 2014, v. 192, n. 1, p. 197, doi. 10.1007/s00408-013-9526-9
- By:
- Publication type:
- Article
Validity of mesothelin in occupational medicine practice.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Response to the letter to editors concerning "Validity of mesothelin in occupational medicine practice".
- Published in:
- 2016
- By:
- Publication type:
- journal article
Detection of Carcinoma-Associated Fibroblasts Derived from Mesothelial Cells via Mesothelial-to-Mesenchymal Transition in Primary Ovarian Carcinomas.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2697, doi. 10.3390/cancers16152697
- By:
- Publication type:
- Article
Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1252, doi. 10.3390/cancers16071252
- By:
- Publication type:
- Article
Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5694, doi. 10.3390/cancers15235694
- By:
- Publication type:
- Article
Immunohistochemical Evaluation of the Expression of Specific Membrane Antigens in Patients with Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4586, doi. 10.3390/cancers15184586
- By:
- Publication type:
- Article
Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3397, doi. 10.3390/cancers15133397
- By:
- Publication type:
- Article
Challenges of Anti-Mesothelin CAR-T-Cell Therapy.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1357, doi. 10.3390/cancers15051357
- By:
- Publication type:
- Article
Metastases to Meningiomas: A Comprehensive Literature Review Including Mediating Proteins.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5877, doi. 10.3390/cancers14235877
- By:
- Publication type:
- Article
The Role of Mesothelin Expression in Serous Ovarian Carcinoma: Impacts on Diagnosis, Prognosis, and Therapeutic Targets.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092283
- By:
- Publication type:
- Article
HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092260
- By:
- Publication type:
- Article